Biotech News

Nkarta to Participate in March Investor Conferences

Nkarta (NKTX)Nkarta2026-06-25 13:46 ESTConference / presentation

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences:

Open original release

Related news

NKTXNkarta2026-06-25 13:46 EST

Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights

NKTXNkarta2026-06-25 13:46 EST

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights

NKTXNkarta2026-06-25 13:46 EST

Nkarta to Participate in a September Investor Conference

NKTXNkarta2026-06-25 13:46 EST

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

NKTXNkarta2026-06-25 13:46 EST

Nkarta to Participate in November Investor Conferences

NKTXNkarta2026-06-25 13:46 EST

Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights

NKTXNkarta2026-06-25 13:46 EST

Nkarta to Participate in Evercore Healthcare Conference

NKTXNkarta2026-06-25 13:46 EST

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

NKTXNkarta2026-06-25 13:46 EST

Nkarta to Participate in Needham Virtual Healthcare Conference

NKTXNkarta2026-06-25 13:46 EST

Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers

View all latest news

Nkarta

Nkarta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

NKTXNkarta2026-06-26 12:01 EST

Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights

NKTXNkarta2026-06-26 12:01 EST

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights

NKTXNkarta2026-06-26 12:01 EST

Nkarta to Participate in a September Investor Conference

NKTXNkarta2026-06-26 12:01 EST

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

NKTXNkarta2026-06-26 12:01 EST

Nkarta to Participate in November Investor Conferences

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States